Accelerate your drug development pipeline with a high‑purity, GMP‑certified GLP‑1 analogue designed for pharmaceutical manufacturers, CROs, and bulk‑API buyers.
Get Free Quote in 24hWhen you are responsible for delivering a new GLP‑1 therapeutic to market, every delay or quality issue translates directly into lost revenue and weakened brand credibility. Below are the most common pain points that keep purchasing managers awake at night.
Most suppliers price Semaglutide above US$1,200 per gram for small‑lot orders, forcing you to allocate excessive budget for R&D batches. The inflated cost often stems from limited production capacity and opaque pricing structures.
Variability in HPLC purity (often <90‑95 %) leads to failed stability studies, additional purification steps, and ultimately regulatory setbacks. Inconsistent impurity profiles also increase the risk of FDA 483 observations.
Typical lead times exceed 45 days, with many shipments delayed by customs holds or carrier failures. Slow delivery elongates clinical‑trial timelines and jeopardizes grant milestones.
Suppliers that lack FDA, EMA, or WHO certifications force you to generate additional documentation, inflating compliance costs by up to 30 %.
What does this mean for you? Higher OPEX, delayed product launches, and a competitive disadvantage in a market where speed and safety are non‑negotiable.
| Parameter | Value | Unit | Standard / Test Method |
|---|---|---|---|
| CAS Number | 910463‑68‑2 | - | N/A |
| Molecular Weight | 4113.58 | g·mol⁻¹ | HR‑MS |
| Purity (HPLC) | ≥99.5 | % | USP USP‑HPLC |
| Appearance | White lyophilized powder | - | Visual inspection |
| Residual Solvent | ≤10 ppm | ppm | GC‑MS (EPA Method 524.2) |
| Microbial Limit | <10³ CFU/g | CFU | USP USP‑420 |
| Stability | ≥24 months | months | ICH‑Q1(R2) |
Our Semaglutide is already powering the following projects:
CAS-1188328-37-1-Selumetinib-Intermediate CAS-1093241-16-7-Semaglutide-Side-Chain CAS-50-56-6-Oxytocin CAS-1400634-44-7-Tirzepatide
“Switching to Global Technology’s Semaglutide cut our raw‑material cost by 28 % and shaved 18 days off our development timeline. The CoA was flawless, and the logistics team handled customs without a hitch.”
“Their GMP‑certified facility gave us the confidence to file a 505(b)(2) NDA. The API met all USP‑HPLC specifications on first‑pass testing.”
Certificates & Compliance: CE, FDA, ISO 9001, GMP, DMF, HACCP, RoHS, CB, VDE, SAA – all downloadable on request.
Our standard MOQ is 500 g. For strategic partners we can accommodate as low as 100 g with a surcharge for expedited handling.
Yes. Our R&D team can tailor peptide length, protection groups, and final dosage form (lyophilized, solution, or tablet‑grade API). Turn‑around for custom batches starts at 21 days.
Every consignment includes a full Certificate of Analysis (CoA), Batch Manufacturing Record (BMR), Material Safety Data Sheet (MSDS), and, if required, a DMF excerpt for FDA filings.
All batches are shipped in insulated, nitrogen‑purged containers with temperature monitoring tags. For tropical routes we add a cold‑chain option (2‑8 °C) at no extra cost for orders >2 kg.

A dedicated Technical Account Manager is assigned to each client. Support includes analytical method transfer, stability‑study consulting, and a 30‑day replacement guarantee for any out‑of‑spec batch.
Limited‑time Offer: Place an order before 31 May 2026 and receive a free 5 g sample plus 10 % discount on the first bulk purchase.
Linda Wu, Procurement Manager, BioNova Ltd. – “The **speed** of delivery (12 days) allowed us to meet our IND filing deadline. Quality was spot‑on – no re‑testing needed.”
James Patel, Technical Director, Orion Pharma – “Their OEM service let us create a custom lyophilized formulation that passed stability at 40 °C. The cost savings were **35 %** versus our previous supplier.”
Sarah Lee, Operations Manager, MedCore International – “Transparent pricing, clear CoA, and a responsive account manager made the whole process painless. Highly recommended for any large‑scale API need.”
Dr. Victor Cheng, Ph.D. in Pharmaceutical Sciences, 15 years in peptide API development, former Senior Scientist at a top‑10 FDA‑registered contract manufacturing organization. Victor has authored over 30 peer‑reviewed papers on GLP‑1 analogues and serves on the International Peptide Society’s Standards Committee. His expertise drives Global Technology’s quality‑first philosophy.
For direct inquiries, reach Victor at vcheng@huanqiukeji9.com or call +86 199 4383 0844.